Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008)

✍ Scribed by E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF OF THE HTRS INVESTIGATORS

• Book ID: 108775708
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 111 KB
• Volume: 17
• Category: Article
• ISSN: 1351-8216
• DOI: 10.1111/j.1365-2516.2010.02483.x